Ixico annual ebitda
2022
2023
2024
2025
Ixico EBITDA Growth & History (IXI)
Ixico's calculated EBITDA was −£2.0M for fiscal 2025.
View full Ixico company overviewIxico annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | −£2.0M | −£428,000 | — |
| 2024 | 2024-09-30 | −£1.6M | −£887,000 | — |
| 2023 | 2023-09-30 | −£707,000 | −£2.3M | — |
| 2022 | 2022-09-30 | £1.6M | — | — |
Ixico ebitda trends
Between the periods ended 2022-09-30 and 2025-09-30, Ixico's ebitda decreased from £1.6M to −£2.0M, a change of −£3.6M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ixico source filings ↗Community posts
IXICO wins £1.5 million of Alzheimer’s imaging and biomarker work
IXICO ($IXI) secured two Alzheimer’s-related contracts with a combined value of approximately £1.5 million. One covers neuroimaging management and analysis for a biotechnology client’s Phase 2b study, with revenue expected over roughly thre ...
